|Start ||End ||Title || |
|8.30 ||9.00 ||REGISTRATION || |
|9.00 ||9.15 ||WELCOME || |
|9.15 ||9.30 || INTERACTIVE SESSION || |
|9.30 ||9.50 ||SESSION 1: PERSPECTIVES FROM A PATIENT & ENTREPRENEUR |
Uri-Go won the Callaghan Innovation C-Prize in 2017 for its wearable bladder sensor to assist those with neurological conditions who cannot sense how full their bladder is. This can include those with a spinal cord injury, Parkinson’s disease and numerous other conditions.
Mike Brown knows the problem first hand after an accident left him paralyzed with a spinal cord injury. He formed Uri-Go with an engineer and a urologist to tackle a very real world problem that affects millions. Mike will share why he is pursuing the development of the Uri-Go sensor, their journey so far, and what lies ahead.
|Keynote – Mike Brown, Co-founder, Uri-Go |
|9.50 ||10.30 ||Q&A USER-CENTRED DESIGN PANEL DISCUSSION – Chair: Nicola Kayes, AUT |
Human-centred design methods promote the voice of the end user that could be patient or clinician. It encourages user engagement within the process of developing medical devices and digital health technologies. Patients and clinicians are more likely to use new technologies if they are seen as relevant, engaging, easy to use and support behaviour change. This session will explore different approaches to ensure the user is central in the technology design process.
•Edgar Rodriguez-Ramirez - Programme Director, Interaction Design Programme, Victoria University of Wellington
• Jenny Kruger - Cofounder and CEO, JunoFem
•Marcus King - Distinguished Engineer, Callaghan Innovation
•Garth Sutherland – Chief Executive, Surgical Design Studios
| 10.30 ||11.00 ||MORNING TEA || |
| 11.00 ||11.20 ||SESSION 2: COMMERCIAL TRANSLATION |
Taking a new medical technology to market is a long process and it can take up to 10 years before a company becomes sustainable. The ability to commercialise is critical if the technology is to achieve its potential in bringing health outcomes to its target population. In New Zealand, we are still learning how to take new medical products to export markets successfully. This session will explore the different technologies coming from New Zealand and the CoRE, and the pathways and strategies to take them to market.
Keynote – Anthony Butler, Chief Medical Officer, MARS Bioimaging – MARS: Exploring NZ imaging technology
|Keynote – Anthony Butler, Chief Medical Officer, MARS Bioimaging – MARS: Exploring NZ imaging technology |
|11.20 ||11.50 ||SESSION SPEAKERS |
•Khoon Lim – Senior Research Fellow, Christchurch Regenerative Medicine and Tissue Engineering Research Group, University of Otago – 3D bioprinting of living tissues
•Peng Du, Co-founder, FlexiMap- From research to commercialization: our journey so far
•Kevin Ross, Chief Executive, Precision Driven Health- The precision driven health partnership
|11.50 ||12.00 ||INTERACTIVE SESSION || |
|12.00 ||13.00 ||CMDT EMERGING RESEARCHER AWARD WINNER + HEALTHTECH AWARD FINALISTS PRESENTATIONS || |
|13.00 ||14.00 ||LUNCH || |
|14.00 ||14.20 ||SESSION 3: CLINICAL TRANSLATION |
Getting new technology into the health sector is challenging and there is limited understanding of the complexity of this process. There is no one size fits all approach but we are able to learn from the experience of others to help make this pathway smoother. Our session speakers will discuss their journeys in taking medical devices and digital health products into the clinical sector.
|Keynote –Jon Herries, Group Manager, Emerging Health Technologies, Ministry of Health |
|14.20 ||13.00 ||SESSION SPEAKERS |
•Maggie-Lee Huckabee, University of Canterbury Rose Centre for Stroke Recovery and Research - How to Rehabilitate a Reflex: You have to see it first
•Susan Binks – Co-founders, Go Well Health – Finding the Channel
•Rosie Dobson - Research Fellow, NIHI, University of Auckland – Implementation issues: Feedback from the Sector
|13.00 ||15.15 ||INTERACTIVE SESSION || |
|15.15 ||15.30 ||ADDRESS FROM THE CORE DIRECTOR |
|Merryn Tawhai, University of Auckland |
|15.30 ||16.00 ||AFTERNOON TEA || |
| 16.00 ||16.20 ||SESSION 4: FUTURE CLINICAL CARE |
To finish off our day we would like to think about our theme of future clinical care. How will care be delivered in the future? How will this trend towards the personalization of care change how we develop, research and translate our medical technologies into practice? Who will be driving this? Who will be responsible for ensuring new technologies get into practice? What would the key barriers be and how might we overcome them?
|Keynote – Terry Reece, Country Head, Clinical Solutions ANZ |
|16.20 ||17.00 ||Q&A PANEL DISCUSSION – CHAIR Merryn Tawhai |
Claudia Wyss – CE, Healthvision NZ
Sasha Kljakovic – Co-founder, Well Revolution
Jon Herries – Group Manager, Emerging Health Technologies, Ministry of Health
Gunnar Grah – Executive Manager Life Sciences and Healthcare, Baden-Württemberg International, BIKEM
|17.00 ||17.30 ||CLOSING & AWARD CEREMONIES || |
|17.30 ||18.30 ||NETWORKING AND DRINKS WITH MTANZ DELEGATES || |